Skip to main content

Market Overview

Adaptimmune Therapeutics PLC (NYSE: ADAP)

4.46 -0.19 (-4.09%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/28/21BarclaysInitiates Coverage OnUnderweight4.0
11/05/20SVB LeerinkMaintainsMarket Perform6.0
8/06/20SVB LeerinkMaintainsMarket Perform10.0
6/01/20MizuhoMaintainsNeutral9.0
4/27/20CitigroupMaintainsBuy5.0
4/22/20MizuhoInitiates Coverage OnNeutral3.0
8/02/19GuggenheimDowngradesNeutral
5/31/19Roth CapitalInitiates Coverage OnBuy7.0
5/30/19CitigroupAssumesBuy8.0
5/07/19SVB LeerinkDowngradesMarket Perform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter